Some studies have reported that suppressing or inhibiting α3β1 in colon carcinoma cells reduces their proliferation, invasion and/or migration [30,31], and activated KRAS has been linked to increased α3β1 expression in colon carcinoma cells [36], suggesting cancer-supportive roles for this integrin. The gene discussed is KRAS; the disease is colon carcinoma.